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Sandeep Basavarajaiah, MD, Mamoon Qadir, MDA 48-year-old man with crescendo anginaexhibited a severe diffuse lesion in the leftanterior descending artery (Figure 1, Online
Video). The option of mammary grafting was ruled
out due to poor distal target. Percutaneous coronary
intervention with drug-eluting stents (DES) would
result in full-metal jacket (>50 mm of overlapping
stents), which poses the long-term risk of stent
thrombosis, and, in addition, restenosis is often
difﬁcult to treat, with high rates of recurrence.FIGURE 1 Coronary Angiogram
Severe diffuse lesion in the left anterior descending artery
involving a large ﬁrst-diagonal branch (arrows) (Online Video).
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several advantages in such lesions because perma-
nent caging of the vessel is avoided and scaffolds
are completely resorbed, preserving the vasomotion;
caging may also provide a future option for surgical
revascularization by remodeling the vessel with no
residual metal work. However, there was a large ﬁrst
diagonal (D1) branch (Figure 2) in the proximal
segment, in which there was mild ostial disease.
Due to thicker BVS struts (156 mm), there was a riskFIGURE 2 Left Anterior Descending Artery/DI1 Bifurcation
Severe diffuse lesion in the left anterior descending artery
involving a large ﬁrst-diagonal branch (arrow).
uthors have reported that they have no relationships
FIGURE 3 Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds
Positioning of 3 overlapping bioresorbable vascular scaffolds (arrows).
FIGURE 4 Percutaneous Coronary Intervention With Drug-Eluting Stents
(A) Positioning of the drug-eluting stent at the bifurcation. (B) Signiﬁcant ostial pinching of the ﬁrst diagonal branch. (C) Final kissing balloon
dilation. In A, the arrow indicates the positioning of the drug-eluting stent at the bifurcation; in B, the arrow indicates the pinching of the
diagonal ostium; and in C, the arrow indicates kissing balloon dilation.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 1 , 2 0 1 5 Basavarajaiah and Qadir
S E P T E M B E R 2 0 1 5 : 1 5 1 8 – 2 1 Hybrid Angioplasty
1519
FIGURE 5 Pre- and Post-Percutaneous Coronary Intervention Angiogram
Angiogram: before (A) and after (B) angioplasty. PCI ¼ percutaneous coronary intervention.
FIGURE 6 Post-Procedure Optical Coherence Tomography
Optical coherence tomography exhibiting well-apposed scaffolds and struts. BVS ¼ bioresorbable vascular scaffold; DES ¼ drug-eluting stent.
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FIGURE 7 Angiogram Post Procedure and at 6-Month Follow-Up
Angiogram 6 months after percutaneous coronary intervention (PCI).
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1521of side-branch compromise, but the beneﬁts of using
BVSs were too enticing not to consider it. Therefore,
after good lesion preparation, we deployed 3 overlap-
ping BVSs extending from the distal to proximal seg-
ments, ending just after the bifurcation (Figure 3).
Subsequently, a second-generation DES was used at
the bifurcation, overlapping the BVSs (Figure 4A).
Due to signiﬁcant ostial pinching of the D1 branch,
the ﬁnal-kissing balloon dilation was performed
(Figures 4B and 4C). An excellent angiographic
result was achieved (Figures 5A and 5B), which was
also conﬁrmed on optical coherence tomography,
revealing well-apposed scaffolds along with good
overlap of the DES and BVSs in the hybrid zone
(Figure 6). A repeat angiogram at 6 months revealed
patent BVSs (Figure 7), and the patient has remained
event free 9 months post-procedure.
Deploying BVSs at the bifurcation would have most
likely compromised the D1 branch. Although there arecases reported in which BVSs were used in bifur-
cations, breaking the scaffold poses the risk of stent
thrombosis. Generally, the use of BVSs should be
avoided in large bifurcations, especially with ostial
disease in the side branch. With this novel hybrid
strategy, we can reap the beneﬁts of BVSs while
possibly avoiding their risks.
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APPENDIX For the supplemental video, please see the online
version of this article.
